0001532023-24-000008.txt : 20240522 0001532023-24-000008.hdr.sgml : 20240522 20240522181714 ACCESSION NUMBER: 0001532023-24-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240520 FILED AS OF DATE: 20240522 DATE AS OF CHANGE: 20240522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gangolli Julian S CENTRAL INDEX KEY: 0001532023 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 24974695 MAIL ADDRESS: STREET 1: 4955 BASELINE AVENUE CITY: SANTA YNEZ STATE: CA ZIP: 93460 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821080209 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 4 1 wk-form4_1716416222.xml FORM 4 X0508 4 2024-05-20 0 0001711279 Krystal Biotech, Inc. KRYS 0001532023 Gangolli Julian S C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 1 0 0 0 0 Common Stock 2024-05-20 4 M 0 20000 22.75 A 20000 D Common Stock 2024-05-20 4 S 0 10930 163.7063 D 9070 D Common Stock 2024-05-20 4 S 0 7090 164.3413 D 1980 D Common Stock 2024-05-20 4 S 0 1980 165.7576 D 0 D Stock Option (Right to Buy) 22.75 2024-05-20 4 M 0 20000 0 D 2029-03-01 Common Stock 20000 0 D The transaction was executed in multiple trades ranging from $163.080 to $164.065. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $164.085 to $164.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $165.160 to $166.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The options were awarded on March 1, 2019 and vested monthly over a three-year period. /s/ Krish Krishnan, as attorney-in-fact for Julian S. Gangolli 2024-05-22